← Leaderboards
Hua Wang
University Of Illinois At Urbana-Champaign
$2,593,656
Attributed
$2,593,656
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $875.4K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,593,656 · 2
By mechanism
R01$2,229,562 · 1
R21$364,094 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Triple-Negative Invasive Breast Carcinoma”
- Elizabeth J Davis · Vanderbilt University Medical Center$2,715,466
- Igor Landry Bado · Baylor College Of Medicine$2,691,173
- Jennifer M. Rosenbluth · University Of California, San Francisco$2,657,653
- Vishnu Hosur · Jackson Laboratory$2,568,438
- Nadine Norton · Mayo Clinic Jacksonville$2,431,858
- Richard Johnson · Saros Therapeutics Inc$2,046,919
Research focus
Triple-Negative Invasive Breast CarcinomaTechnologyMetabolicMembraneSuccessSurfaceDendritic CellsImmunomodulatorsClinical TranslationMediatingPolysaccharidesResponseAntigensSugarAdjuvantCytotoxic T-LymphocytesChemistryGlycoengineeringCancer VaccinesAntigen PresentationImmunotherapyLabelCell MembraneTumor
Grant awards (6)
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells$875,408
R01 · FY2025 · CA · contact PI
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells$431,451
R01 · FY2024 · CA · contact PI
Metabolic tagging of tumor exosomes for developing enhanced exosome vaccines$195,200
R21 · FY2024 · CA · contact PI
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells$464,426
R01 · FY2023 · CA · contact PI
Metabolic tagging of tumor exosomes for developing enhanced exosome vaccines$168,894
R21 · FY2023 · CA · contact PI
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells$458,277
R01 · FY2022 · CA · contact PI